Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Nuclear Medicine and Biology
|
June 25, 1998
Synthesis and characterization of a 11C-labelled derivative of S12968: an attempt to image in vivo brain calcium channels
F Dollé, H Valette, F Hinnen, et al.
The American Journal of Psychiatry
|
February 7, 2001
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation
M Martinot, V Bragulat, E Artiges, et al.
Neuroimage
|
June 1, 1994
Rat brain acetylcholinesterase visualized with [11C]physostigmine
A M Planas, C Crouzel, F Hinnen, et al.
Bioorganic & Medicinal Chemistry
|
April 1, 1997
Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging
F Dollé, F Hinnen, H Valette, et al.
Nuclear Medicine and Biology
|
March 30, 1999
Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET
H Valette, F Dollé, I Guenther, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2001
Myocardial kinetics of the (11)C-labeled enantiomers of the Ca(2+) channel inhibitor S11568: an in vivo study
H Valette, F Dollé, I Guenther, et al.
Life Sciences
|
March 11, 1999
Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo
H Valette, M Bottlaender, F Dollé, et al.
Journal of Medicinal Chemistry
|
June 23, 1999
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors
F Doll, L Dolci, H Valette, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 4, 2001
Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa
T Poyot, F Condé, M C Grégoire, et al.
Organic & Biomolecular Chemistry
|
January 14, 2016
Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applications
B Kuhnast, A El Hadri, R Boisgard, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Nuclear Medicine and Biology
|
June 25, 1998
Synthesis and characterization of a 11C-labelled derivative of S12968: an attempt to image in vivo brain calcium channels
F Dollé, H Valette, F Hinnen, et al.
The American Journal of Psychiatry
|
February 7, 2001
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation
M Martinot, V Bragulat, E Artiges, et al.
Neuroimage
|
June 1, 1994
Rat brain acetylcholinesterase visualized with [11C]physostigmine
A M Planas, C Crouzel, F Hinnen, et al.
Bioorganic & Medicinal Chemistry
|
April 1, 1997
Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging
F Dollé, F Hinnen, H Valette, et al.
Nuclear Medicine and Biology
|
March 30, 1999
Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET
H Valette, F Dollé, I Guenther, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2001
Myocardial kinetics of the (11)C-labeled enantiomers of the Ca(2+) channel inhibitor S11568: an in vivo study
H Valette, F Dollé, I Guenther, et al.
Life Sciences
|
March 11, 1999
Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo
H Valette, M Bottlaender, F Dollé, et al.
Journal of Medicinal Chemistry
|
June 23, 1999
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors
F Doll, L Dolci, H Valette, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 4, 2001
Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa
T Poyot, F Condé, M C Grégoire, et al.
Organic & Biomolecular Chemistry
|
January 14, 2016
Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applications
B Kuhnast, A El Hadri, R Boisgard, et al.
Page
of 2